...
首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >A modified hydrophobic ion-pairing complex strategy for long-term peptide delivery with high drug encapsulation and reduced burst release from PLGA microspheres
【24h】

A modified hydrophobic ion-pairing complex strategy for long-term peptide delivery with high drug encapsulation and reduced burst release from PLGA microspheres

机译:一种改进的疏水离子配对复合策略,具有高药物包封的长期肽递送和从PLGA微球的爆发释放减少

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Poor encapsulation and high initial burst were two major obstacles for the water-soluble peptide drug loaded microspheres preparation using the industrial emulsification method. In the present study, we hypothesized that the hydrophobic ion-pairing (HIP) complex strategy with a further healing of the pores within the microspheres may improve drug encapsulation and initial burst release. DSS was chosen as the most suitable one among the three test ion-pairing agents (SDS, DSS and STC) due to its high binding efficiency with drug and reversible dissociation capacity in presence of counter ions. The formation of HIP complex between octreotide acetate and DSS successfully reversed the highly water-soluble nature of the drug. A specific S/O/W method was adopted to encapsulate such drug containing HIP complex. The encapsulation efficiency of the drug was greatly improved compared with the conventional W1/O/W2 method (from 44% to 90%). Under the optimal healing conditions (the healing time 6 h, temperature 40 degrees C and 4% DEP content), the pores within the microspheres were effectively healed. Initial burst amount of octreotide acetate in S/O/W microspheres decreased to 3.56%. The pore healing effect was further confirmed by the scanning electron microscopy and fluorescence microscopy results. In the process of testing the drug release performance of such new strategy in vitro and in vivo, a more satisfactory single phase release profile with sustained and steady drug release was observed. These results suggested that the modified HIP strategy could be a promising platform for water-soluble peptide encapsulation with high encapsulation efficiency, low initial burst and stable drug release mechanism.
机译:使用工业乳化方法,封装和高初始突发差是水溶性肽药物负载的微球的两个主要障碍。在本研究中,我们假设具有在微球内进一步愈合的疏水离子配对(HIP)复合策略可以改善药物包封和初始爆发释放。由于其在抗衡离子存在下具有高结合效率,因此选择DSS作为三种试验离子配对剂(SDS,DSS和STC)中最合适的一种。糖苷酸乙酸酯和DSS之间的髋骨形成成功逆转了药物的高度水溶性性质。采用特异性的S / O / W方法包封含有髋骨的这种药物。与常规W1 / O / W2方法(44%至90%)相比,药物的包封效率大大提高了。在最佳愈合条件下(愈合时间6小时,温度40摄氏度和4%DEP含量),微球内的孔有效地愈合。 S / O / W微球中乙酸乙酸酯的初始突发量降至3.56%。通过扫描电子显微镜和荧光显微镜结果进一步证实了孔愈合效果。在测试体外和体内这种新策略的药物释放性能的过程中,观察到具有持续和稳定的药物释放的更令人满意的单相释放曲线。这些结果表明,改良的髋浦策略可能是具有高封装效率,初始突发和稳定的药物释放机理的高封装肽包封的有希望的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号